BANK VONTOBEL/PUT/ROCHE GS/230/0.1/21.06.24 Share Price

Warrant

DE000VV4MHU7

Market Closed - Bid/Ask 12:28:23 03/05/2024 pm IST After market 11:37:18 pm
1.67 EUR +42.74% Intraday chart for BANK VONTOBEL/PUT/ROCHE GS/230/0.1/21.06.24 1.545 -7.49%
Current month+3.54%
1 month+56.00%
Date Price Change Volume
03/24/03 1.67 +42.74% 0
02/24/02 1.17 +3.54% 0
30/24/30 1.13 +2.73% 0
29/24/29 1.1 -12.00% 0
26/24/26 1.25 +1.63% 0

Delayed Quote Börse Stuttgart

Last update May 03, 2024 at 12:28 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Vontobel Vontobel
WKN VV4MHU
ISINDE000VV4MHU7
Date issued 04/07/2022
Strike 230 CHF
Maturity 21/06/2024 (49 Days)
Parity 10 : 1
Emission price 0.88
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.77
Lowest since issue 0.46
Spread 0.19
Spread %11.73%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
214.1 CHF
Average target price
279.4 CHF
Spread / Average Target
+30.49%
Consensus